Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Senescence modulated cardiac repair with pluripotent stem cell-derived cardiomyocytes.

Stem cell research & therapy·2026
Same author

Early health technology assessment (eHTA) approaches focused on human stem cell-related technologies: a scoping review protocol.

BMJ open·2026
Same author

Scaling-Up Vertical-Wheel Bioreactors Based on Cell Aggregate Exposure to Shear Stress and Energy Dissipation Rate.

Annals of biomedical engineering·2026
Same author

Advancing regenerative medicine with RNA nanotechnology for chronic and end organ diseases.

Communications medicine·2026
Same author

Human pluripotent stem cell-derived atrioventricular node-like pacemaker cells exhibit biological conduction bridge properties.

Cell stem cell·2026
Same author

Bright Ferritin for Non-Invasive MRI Monitoring of the Fate of Transplanted hPSC-Cardiomyocytes in the Infarcted Rat Heart.

Magnetic resonance in medicine·2026

Related Experiment Video

Updated: Jun 20, 2026

Generation, High-Throughput Screening, and Biobanking of Human-Induced Pluripotent Stem Cell-Derived Cardiac Spheroids
09:23

Generation, High-Throughput Screening, and Biobanking of Human-Induced Pluripotent Stem Cell-Derived Cardiac Spheroids

Published on: March 10, 2023

Cardiac applications for human pluripotent stem cells.

Yuji Shiba1, Kip D Hauch, Michael A Laflamme

  • 1Department of Pathology, University of Washington, Seattle, WA 98109, USA.

Current Pharmaceutical Design
|August 20, 2009
PubMed
Summary
This summary is machine-generated.

Human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) offer a renewable source of cardiomyocytes for cardiac repair and drug testing. Challenges include purity, delivery, and immune rejection for successful clinical application.

More Related Videos

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry
13:13

High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry

Published on: September 23, 2014

Related Experiment Videos

Last Updated: Jun 20, 2026

Generation, High-Throughput Screening, and Biobanking of Human-Induced Pluripotent Stem Cell-Derived Cardiac Spheroids
09:23

Generation, High-Throughput Screening, and Biobanking of Human-Induced Pluripotent Stem Cell-Derived Cardiac Spheroids

Published on: March 10, 2023

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
06:37

Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair

Published on: February 3, 2017

High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry
13:13

High Efficiency Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes and Characterization by Flow Cytometry

Published on: September 23, 2014

Area of Science:

  • Stem cell biology
  • Cardiovascular research

Background:

  • Human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) self-renew and differentiate into cardiomyocytes.
  • These cells offer a potential source for cardiac therapies, drug screening, and developmental modeling.

Purpose of the Study:

  • To review the phenotype of stem cell-derived cardiomyocytes.
  • To summarize preclinical transplantation studies.
  • To discuss challenges and potential solutions for cardiac repair applications.

Main Methods:

  • Phenotypic characterization of hESC- and hiPSC-derived cardiomyocytes.
  • Review of preclinical transplantation studies in cardiac repair models.
  • Analysis of challenges in clinical translation.

Main Results:

  • Stem cell-derived cardiomyocytes exhibit a clear cardiac phenotype and robust proliferation.
  • Preclinical studies demonstrate proof-of-concept for infarct repair and biological pacemakers.
  • Major hurdles include achieving high purity, effective delivery, and overcoming immune rejection.

Conclusions:

  • Stem cell-derived cardiomyocytes hold promise for cardiac regeneration and research.
  • Overcoming challenges in purity, delivery, and immunogenicity is crucial for clinical success.